BELLEZZA, Guido
 Distribuzione geografica
Continente #
NA - Nord America 5.808
EU - Europa 4.739
AS - Asia 3.546
SA - Sud America 644
AF - Africa 65
OC - Oceania 15
Continente sconosciuto - Info sul continente non disponibili 8
AN - Antartide 1
Totale 14.826
Nazione #
US - Stati Uniti d'America 5.652
SG - Singapore 1.547
IT - Italia 1.014
IE - Irlanda 826
UA - Ucraina 711
HK - Hong Kong 602
CN - Cina 592
BR - Brasile 545
RU - Federazione Russa 458
SE - Svezia 443
DE - Germania 361
VN - Vietnam 325
FI - Finlandia 251
KR - Corea 232
GB - Regno Unito 176
FR - Francia 127
CA - Canada 102
RO - Romania 83
PL - Polonia 54
IN - India 42
AR - Argentina 38
AT - Austria 38
BE - Belgio 38
TR - Turchia 38
MX - Messico 37
JP - Giappone 32
NL - Olanda 31
CH - Svizzera 25
ES - Italia 24
EC - Ecuador 20
BD - Bangladesh 19
ZA - Sudafrica 17
UZ - Uzbekistan 16
PT - Portogallo 15
IQ - Iraq 14
AU - Australia 13
CZ - Repubblica Ceca 13
GR - Grecia 13
ID - Indonesia 12
PK - Pakistan 12
LB - Libano 11
MA - Marocco 11
EG - Egitto 9
LT - Lituania 9
PY - Paraguay 9
IL - Israele 8
BG - Bulgaria 7
CO - Colombia 7
CL - Cile 6
EU - Europa 6
JO - Giordania 6
AE - Emirati Arabi Uniti 5
AL - Albania 5
BO - Bolivia 5
CI - Costa d'Avorio 5
PE - Perù 5
SK - Slovacchia (Repubblica Slovacca) 5
AZ - Azerbaigian 4
GT - Guatemala 4
KE - Kenya 4
TN - Tunisia 4
UY - Uruguay 4
VE - Venezuela 4
DK - Danimarca 3
LK - Sri Lanka 3
PA - Panama 3
TH - Thailandia 3
A2 - ???statistics.table.value.countryCode.A2??? 2
BW - Botswana 2
CR - Costa Rica 2
HN - Honduras 2
KG - Kirghizistan 2
KH - Cambogia 2
MD - Moldavia 2
MN - Mongolia 2
NO - Norvegia 2
NP - Nepal 2
OM - Oman 2
PH - Filippine 2
TT - Trinidad e Tobago 2
TW - Taiwan 2
UG - Uganda 2
AM - Armenia 1
AO - Angola 1
AQ - Antartide 1
BA - Bosnia-Erzegovina 1
BB - Barbados 1
BN - Brunei Darussalam 1
CG - Congo 1
CY - Cipro 1
DO - Repubblica Dominicana 1
DZ - Algeria 1
EE - Estonia 1
GA - Gabon 1
GH - Ghana 1
GM - Gambi 1
GN - Guinea 1
HU - Ungheria 1
IR - Iran 1
JM - Giamaica 1
Totale 14.811
Città #
Chandler 1.003
Singapore 967
Dublin 825
Hong Kong 601
Jacksonville 386
San Mateo 367
Boardman 329
Perugia 283
Ashburn 277
Santa Clara 247
Seoul 232
Ann Arbor 189
Medford 184
Princeton 183
Altamura 159
Beijing 157
Dong Ket 156
Wilmington 147
Moscow 145
Munich 135
Lawrence 120
Andover 107
Los Angeles 94
Piscataway 81
Bucharest 79
New York 74
Helsinki 65
Ho Chi Minh City 62
São Paulo 57
Saint Petersburg 53
The Dalles 52
Ottawa 49
Rome 41
Woodbridge 40
Des Moines 39
Shanghai 37
Brussels 36
Hanoi 36
Redmond 36
Norwalk 35
Frankfurt am Main 31
Tokyo 31
San Paolo di Civitate 30
Turku 30
Dallas 27
Milan 27
Houston 24
London 23
Redwood City 23
Stockholm 23
Warsaw 23
Montreal 21
Chicago 20
Nuremberg 20
Auburn Hills 19
Philadelphia 19
San Francisco 19
Brooklyn 17
Chennai 17
Falkenstein 17
Izmir 17
Phoenix 17
Atlanta 16
Kraków 16
Poplar 15
Columbus 14
Curitiba 13
Guangzhou 13
Amsterdam 12
Boston 12
Denver 12
Hefei 12
Mexico City 12
Orem 12
Rio de Janeiro 12
Toronto 12
Council Bluffs 11
Falls Church 11
Haiphong 11
Bologna 10
Brasília 10
Lappeenranta 10
Salvador 10
Vienna 10
Den Haag 9
Florence 9
Bexley 8
Guarulhos 8
Johannesburg 8
Quito 8
West Jordan 8
Ankara 7
Belo Horizonte 7
Campinas 7
Campo Grande 7
Cuiabá 7
Palermo 7
Seattle 7
Simi Valley 7
Sydney 7
Totale 9.047
Nome #
Angiosarcoma primitivo del surrene 224
Granuloma piogenico: revisione della letteratura e presentazione di un caso 214
Assessment of TILs, IDO-1, and PD-L1 in resected non-small cell lung cancer: an immunohistochemical study with clinicopathological and prognostic implications 176
Espressione della sialoproteina ossea, dell’osteopontina e dell’osteonectina nel carcinoma prostatico 160
Condromatosi sinoviale primitiva dei tessuti molli. 160
Aspirato con ago sottile dei noduli tiroidei: striscio convenzionale vs preparato in strato sottile. 143
Primary mucinous carcinoma of the skin 129
Garcinoic Acid Is a Natural and Selective Agonist of Pregnane X Receptor 127
Nuovi metodi di rilevazione delle micrometastasi linfonodali. XXIII Congresso Nazionale di Chirurgia Oncologica 123
p53 overexpression predicts the resistance to chemotherapy in advanced non small cell lung cancer (NSCLC)". 122
Valutazione anatomo-patologica dell’unità feto-placentare nella morte prenatale. 122
The correlation of protein peroxidation with morphological changes in experimental oestradiol-induced carcinogenesis 117
Significato prognostico dell’espressione immunoistochimica di Insulin like growth facor receptor 1 (IGFR-1) ed epidermal growth factor receptor (EGFR) nei carcinomi non a piccole cellule del polmone (NSCLC). 115
Appendiceal mucocele. A case report and literature review 115
Leiomyoma of the breast: case report and review of the literature. 114
Nested Type Bladder Cancer: A Tricky Entity A Report of Two Cases 113
Prognostic Role of Erbb Family Receptors, Myc and Mitogen-activated Protein Kinase (mapk) In Patients With Early-stage Non Small-cell Lung Cancer 112
Indoleamine 2,3-dioxygenase 2 immunohistochemical expression in a resected non-small cell lung cancer series 111
Immunohistochemical expression of IMP3 in non small cell lung cancer. 108
Ossificazione eterotopica e patologia tiroidea: descrizione di 6 casi e revisione della letteratura 107
Apocrine intraductal carcinomas arising in two fibroadenomas: report of an unusual case. 107
Biological Prognostic Factors for early stage completely resected NSCLC 107
6th National Conress of Medical Oncology 107
Gene identification for risk of relapse in stage I lung adenocarcinoma patients: A combined methodology of gene expression profiling and computational gene network analysis 107
CD10 is frequently expressed in classical seminomas. 105
Prognostic impact of alternative splicing-derived hMENA isoforms in resected, node-negative, non-small-cell lung cancer 104
Ruolo dei marcatori biologici negli stadi iniziali dei NSCLC tattati con resezione chirurgica radicale. Congresso Nazionale SICO 103
P-126 * PROGNOSTIC SIGNIFICANCE OF MYC AND HUMAN TELOMERASE GENE AMPLIFICATION IN SURGICALLY TREATED EARLY STAGE NON-SMALL CELL LUNG CANCER 103
Relevance of p53, bcl-2 and Rb expression on resistance to cisplatin-based chemotherapy in advanced non small cell lung cancer (NSCLC) 102
Espressione di MKP-1 nei noduli iperplastici, adenomi e carcinomi papillari della tiroide. 102
Espressione di EGFR e timidilato sintetasi nel carcinoma rettale: correlazioni anatomo-cliniche e significato prognostico - IV Congresso Nazionale di Anatomia Patologica 101
Classification Model to Estimate MIB-1 (Ki 67) Proliferation Index in NSCLC Patients Evaluated With 18F-FDG-PET/CT 100
Predictors of resistance to chemotherapy and prognosis in advanced non-small cell lung cancer. 99
Coexpression of HER-2/neu and p53 in breast cancer identifies a subset with an aggressive biopathological profile. 99
Fine needle aspiration cytology of thyroid nodules: conventional smears vs thin layer technique 98
1° Simposio Nazionale di Citopatologia "Dallo screening alla citologia diagnostica" 98
Indoleamine 2,3-Dioxygenase 2 Immunohistochemical Expression in Resected Human Non-small Cell Lung Cancer: A Potential New Prognostic Tool 97
Carcinoma della mammella pT1a: studio clinico-patologico 95
Attivazione in situ delle metalloproteinasi da parte del sistema fibrinolitico come meccanismo patogenetico della rottura della placca aterosclerotica. 93
An additional case of breast tumor resembling the tall cell variant of papillary thyroid carcinoma. 93
Mitotic index matter: how to improve the assessment of mitosis in order to better classify G2 breast cancer and luminal A category 93
Akt phosphorylation and gefitinib efficacy in patients with advanced non-small-cell lung cancer 91
Identification of EML4-ALK Rearrangement and MET Exon 14 R988C Mutation in a Patient with High-Grade Neuroendocrine Lung Carcinoma Who Experienced a Lazarus Response to Crizotinib 90
ATTIVAZIONE IN SITU DELLE METALLOPROTEINASI DA PARTE DEL SISTEMA FIBRINOLITICO COME MECCANISMO PATOGENETICO DELLA ROTTURA DELLA PLACCA ATEROSCLEROTICA. 89
Biological markers and DNA flow cytometric analysis in radically resected patients with non-small cell lung cancer. A study of the Perugia Multidisciplinary Team for Thoracic Tumors. 89
Optimization of patient selection for EGFR-TKIs in advanced non-small cell lung cancer by combined analysis of KRAS, PIK3CA, MET, and non-sensitizing EGFR mutations. 89
Anaplastic lymphoma kinase immunohistochemistry scores do not predict sensitivity to crizotinib in fluorescence in situ hybridization-positive non-small cell lung cancer patients. 89
Effectiveness and predictability of pleurodesis with the Tachosil® surgical patch compared with talc poudrage: An experimental study 89
SIGNIFICATO PROGNOSTICO DI ALCUNI PARAMETRI BIOPATOLOGICI IN 99 CASI DI CARCINOMA DEL POLMONE NON-MICROCITOMA STADIO I-II. Atti congresso congiunto: Società italiana Anatomia Patologica e Citologia Diagnostica (SIAPEC) e International Academy of Pathology (IAP). Pathologica Vol 91 88
Tumori a cellule granulari (TCG): nuovi marcatori imunoistochimici. 86
High coexpression of both insulin-like growth factor receptor-1 (IGFR-1) and epidermal growth factor receptor (EGFR) is associated with shorter disease-free servival in resected non-small-cell lung cancer patients. 86
Kynurenine/Tryptophan Ratio as a Potential Blood-Based Biomarker in Non-Small Cell Lung Cancer 86
Future options for ALK-positive non-small cell lung cancer 84
A population survival model for breast cancer. 83
Prognostic implication of aquaporin 1 overexpression in resected lung adenocarcinoma 83
Tumore stromale gastrointestinale (GIST) in diverticolo di Meckel: descrizione di due casi 82
A combined approach for thyroid fine needle aspiration: liquid based cytology, cell block and immunohistochemical methods with the implementation of the Cellient™ automated cell block system 81
Detection of HER-/neu (c-erbB-2). Overexpression and amplification in breast carcinomas with ambiguous immunohistochemical results. A further contribution to defining the role of fluorescent in situ hybridization. 81
Espressione delle proteine osteogenetiche nel carcinoma prostatico: correlazioni anatomo-cliniche e significato prognostico 81
Endometriosis-associated skeletal muscle regeneration: a hitherto undescribed entity and a potential diagnostic pitfall. 81
Detection of HER-2/neu (c-erbB-2) overexpression and amplification in breast carcinomas with ambiguous immunohistochemical results. A further contribution to defining the role of fluorescent in situ hibridization. 81
Could thymomectomy be a reasonable option for non-myasthenic thymoma patients? 81
High PD-L1/IDO-2 and PD-L2/IDO-1 Co-Expression Levels Are Associated with Worse Overall Survival in Resected Non-Small Cell Lung Cancer Patients 81
Espressione delle citocheratine basali nei carcinomi mammari pT1b: studio clinico patologico. 80
The clinical relevance of Bcl-2, Rb, p53 overexpression in advanced non small cell lung cancer. 80
Espressione dei recettori HER nei carcinomi non a piccole cellule del polmone 80
Low dentin matrix protein 1 expression correlates with skeletal metastases development in breast cancer patients and enhances cell migratory capacity in vitro. 79
Immunohistochemical analisis of extracellular matrix metalloproteinase inducer (EMMPRIN/CD147) in papillary thyroid carcinoma (PYC): a marker of lymph node metastasis. 79
Evaluation of the prognostic role of vascular endothelial growth factor and microvessel density in stages I and II breast cancer patients. 79
Concomitant high gene copy number and protein overexpression of IGF1R and EGFR negatively affect disease-free survival of surgically resected non-small-cell-lung cancer patients 79
Biological prognostic factors for early stage completely resected non-small cell lung cancer. 79
Higher tlr7 gene expression predicts poor clinical outcome in advanced nsclc patients treated with immunotherapy 79
Targeting the KRAS variant for treatment of non-small cell lung cancer: Potential therapeutic applications 78
Modified gene expression of alveolar-capillar membrane, extracellular matrix and membrane proteins after induction chemotherapy for Non-Small Cell Lung Cancer 78
Reverse phase protein array (RPPA) combined with computational analysis to unravel relevant prognostic factors in non- small cell lung cancer (NSCLC): a pilot study 78
Carcinoma della mammella pT1a: studio clinico-patologico 77
Confronto tra citologia aspirativa con ago sottile e parametri eco-color-doppler nei noduli tiroidei 77
Breast cancer in young women: clinicopathological features and biological specificity. 77
Evaluation of electrospun bioresorbable scaffolds for tissue-engineered urinary bladder augmentation. 77
Observational analysis on inflammatory reaction to talc pleurodesis: Small and large animal model series review 77
INSL4 as prognostic marker for proliferation and invasiveness in non-small-cell lung cancer 76
Co-expression of receptors of the HER family correlates with clinical outcome in non-small cell lung cancer (NSCLC). 76
Pathway Activation Mapping of Kras Wild Type and Mutated Adenocarcinomas of the Lung: New Implications For Patient Stratification For Map Kinase Pathway Inhibition 76
Pleurodesis with Thulium Cyber Laser versus talc poudrage: a comparative experimental study 76
Dyskerin and TERC expression may condition survival in lung cancer patients 76
Clinical Outcome With Platinum-Based Chemotherapy in Patients With Advanced Nonsquamous EGFR Wild-Type Non-Small-Cell Lung Cancer Segregated According to KRAS Mutation Status. 76
Potential prognostic role of Indoleamine 2,3-dioxygenase 2 in human non-small cell lung cancer: an immunohistochemical study. 75
Osimertinib 75
IMP3 protein expression in triple negative breast carcinoma. 74
How might treatment of ALK-positive non-small cell lung cancer change in the near future? 74
Precision medicine against ALK-positive non-small cell lung cancer: beyond crizotinib 74
Biopathologic Profile of breast cancer in core biopsy: is it always a valid method? 74
Ercc1 Mrna Expression and Kras Mutation Status In Egfr Wild Type (wt) Advanced Non-small Cell Lung Cancer (nsclc) Patients 73
Comparison between fine needle aspiration cytology and ultrasound features in thyroid nodules: an US score to select thyroid nodules requiring FNA. 73
A New Medium (HistoCold) for Surgical Specimens Preserving to Improve the Preanalytic Issues in Histopathological Samples Handling: Morphologic and Antigenic Analysis 72
HER family receptors expression in squamous cell carcinoma of the tongue: study of the possible prognostic and biologic significance 72
Carcinomi mammari “triple negative”: studio dei fattori prognostici e predittivi 72
Osimertinib in patients with advanced epidermal growth factor receptor T790M mutation-positive non-small cell lung cancer: rationale, evidence and place in therapy 72
Modificazioni del profilo biopatologico del carcinoma della mammella: un ulteriore effetto dello screening mammografico? 71
Carcinomi mammari "triple negative": studio dei fattori prognostici e predittivi. 70
Totale 9.506
Categoria #
all - tutte 69.843
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 69.843


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021800 0 0 0 0 0 101 136 21 165 53 132 192
2021/20221.583 37 287 30 91 30 22 20 463 48 91 182 282
2022/20232.968 219 540 37 275 257 291 12 136 1.066 9 101 25
2023/20241.229 82 117 56 15 10 28 317 48 140 42 181 193
2024/20252.872 74 303 158 89 383 114 91 255 534 169 438 264
2025/20263.031 491 442 323 802 818 155 0 0 0 0 0 0
Totale 15.342